Congress has found that reasonable control and regulation of the labeling of pharmaceutical drugs is necessary for the protection of the public health, safety and welfare. As a result, Congress has authorized the President to issue rules and regulations to reduce confusion among consumers and medical providers with respect to drugs similar in physical appearance. Has Congress made a valid delegation? Why or why not?